|
RAI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13630002576792E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17240000432994E-08 |
| Normal-vs-Stage2 |
2.664000E-03 |
| Normal-vs-Stage3 |
4.65159999962772E-07 |
| Normal-vs-Stage4 |
7.90370000003371E-07 |
| Stage1-vs-Stage2 |
5.540000E-01 |
| Stage1-vs-Stage3 |
7.990600E-01 |
| Stage1-vs-Stage4 |
3.642000E-01 |
| Stage2-vs-Stage3 |
4.699400E-01 |
| Stage2-vs-Stage4 |
2.250600E-01 |
| Stage3-vs-Stage4 |
4.962600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47379997095243E-09 |
| Normal-vs-AfricanAmerican |
3.82250000000584E-05 |
| Normal-vs-Asian |
1.93277999999131E-05 |
| Caucasian-vs-AfricanAmerican |
1.478230E-01 |
| Caucasian-vs-Asian |
2.289600E-01 |
| AfricanAmerican-vs-Asian |
6.974600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17759999979295E-07 |
| Normal-vs-Female |
3.64490004844953E-09 |
| Male-vs-Female |
7.729400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.56789999451146E-08 |
| Normal-vs-Age(41-60Yrs) |
1.05509999626108E-08 |
| Normal-vs-Age(61-80Yrs) |
3.80939999999885E-05 |
| Normal-vs-Age(81-100Yrs) |
7.315000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.934200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.571400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.524800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.773200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.541400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.121600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.234800E-01 |
| Classical-VS-Follicular |
1.71369999968363E-07 |
| Classical-VS-Other |
1.560230E-01 |
| Classical-VS-Normal |
3.16913162379251E-12 |
| Tall-VS-Follicular |
3.322400E-02 |
| Tall-VS-Other |
3.550000E-01 |
| Tall-VS-Normal |
1.375910E-04 |
| Follicular-VS-Other |
7.704800E-01 |
| Follicular-VS-Normal |
1.166820E-01 |
| Other-VS-Normal |
2.273200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.85220000015596E-07 |
| Normal-vs-N1 |
2.02669999999072E-05 |
| N0-vs-N1 |
4.251800E-01 |
|
|
